Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

There is no fulltext present in this item.

Title:	Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
Author(s):	Janssen, L.; Frambach, S.; Allard, N.A.E.; Hopman, M.T.E. ; Schirris, T.J.J.; Voermans, N.C. ; Rodenburg, R.J.T. ; Blijlevens, N.M.A. ; Timmers, S.
Publication year:	2019
Source:	Leukemia, vol. 33, iss. 8, (2019), pp. 2116-2120
ISSN:	0887-6924
DOI:	https://doi.org/10.1038/s41375-019-0443-7
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : http://hdl.handle.net/2066/208380
Display more details
Subject:	Radboudumc 11: Renal disorders RIMLS: Radboud Institute for Molecular Life Sciences Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience Radboudumc 6: Mitochondrial diseases RIHS: Radboud Institute for Health Sciences Radboudumc 6: Mitochondrial diseases RIMLS: Radboud Institute for Molecular Life Sciences Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences
Organization:	Internal Medicine Physiology Pharmacology-Toxicology Neurology Amalia Childrens Hospital Laboratory Medicine Haematology
Journal title:	Leukemia
Volume:	vol. 33
Issue:	iss. 8
Page start:	p. 2116
Page end:	p. 2120